Viking Therapeutics (VKTX) announced that results from the company’s Phase 2b clinical trial of VK2809, the company’s novel liver-selective thyroid hormone receptor beta agonist, in patients with ...

VK2809 found that those on the medicine saw statistically significant reductions in liver fat, meeting the primary endpoint.

Pomerantz LLP is investigating claims on behalf of investors of Viking Therapeutics, Inc. ("Viking" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...

The 19th G20 Summit is being held in Rio de Janeiro, Brazil, from November 18 to 19. Chinese President Xi Jinping said at the summit that China has announced the decision to give all the least ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

It's no secret that the venture capital industry is facing a liquidity crisis as IPOs and other exits remain few and far ...

The nonprofit organization helping downtown Colorado Springs serve as the economic, cultural, and civic heart has announced ...

Trump Suggests Use of Emergency Powers and the Military for Deportations Donald Trump addressed his plans for mass deportations in a social media post. He is expected to interview candidates for ...

A view of the new Beijing Stock Exchange at the Financial Street, in Beijing, China, November 15, 2021. REUTERS/Tingshu Wang/File Photo Asian stocks rose on Tuesday while U.S. bond yields and the ...

Stay informed. Wherever you are. Read, Watch, Listen to Australian and world news that matters, everywhere you go. LIVE stream SBS World News TV Bulletin from 6:30pm AEST.

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...